Aurobindo Pharma buys Khandelwal Labs unit for ₹325 cr

Aurobindo Pharma strengthens its domestic formulations market with a ₹325 crore acquisition of Khandelwal Laboratories' non-oncology business. The deal includes 23 established brands and boosts presence in pain & anti-infective segments. Read more.

Tata Motors Sales Jump 25% in December 2024

Tata Motors announces robust December 2024 sales, registering a 25% year-on-year growth. Discover the key drivers behind this impressive performance and the outlook for 2025.

5 Indian Sectors Beat Nifty in Volatile 2025 Market

Despite a tough 2025 for Indian equities, five sectors soared: PSU Banks, Metals, Auto, Defence, and Private Banks. Discover the drivers behind their stellar performance and what it means for investors.

Page 459 of 891